+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 223 Pages
  • March 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953628
The Global Hyperpigmentation Treatment Market size is expected to reach $9.3 billion by 2030, rising at a market growth of 8.2% CAGR during the forecast period.

There is a notable increase in awareness about skincare practices among the population in Mexico. The Mexican population has a growing cosmetic consciousness, with individuals expressing a desire for clear and even-toned skin. Consequently, the North America region would generate a revenue of USD 1,818.2 Million in 2022. The high prevalence of hyperpigmentation in North America creates a substantial demand for effective treatment solutions. North America boasts advanced healthcare infrastructure, including well-equipped dermatological clinics and hospitals.



Social media platforms amplify skincare trends and routines, including Instagram, TikTok, and YouTube. Influencers and skincare enthusiasts showcase their hyperpigmentation treatment journeys, fostering awareness and inspiring others to explore similar interventions. Therefore, the hyperpigmentation treatment market is expanding significantly due to the social media influence and beauty standards.

Additionally, Individuals with a higher disposable income can afford professional hyperpigmentation treatments dermatologists and skincare professionals offer. This includes procedures such as laser therapy, chemical peels, and other advanced interventions. Thus, because of the higher level of disposable income, the market is anticipated to increase significantly.

However, Affordability challenges may contribute to disparities in treatment access across different demographics and socioeconomic groups. This can lead to unequal distribution of hyperpigmentation treatment benefits. Disparities in treatment access create challenges for achieving inclusive market growth, as certain population segments may be underserved or excluded due to financial constraints. Thus, high treatment costs can slow down the growth of the market.

Furthermore, Lockdowns, restrictions, and temporary closures of production facilities led to interruptions in the supply of raw materials and finished products. This disruption resulted in delays in the production and distribution of hyperpigmentation treatment products, affecting the availability of certain formulations, topical agents, and devices in the market. Thus, the COVID-19 pandemic had a moderate effect on the market.

By Treatment Type Analysis

By treatment type, the market is categorized into topical agent, photo therapy, and microdermabrasion. In 2022, the topical agent segment held a 44.40 % revenue share in the market. Topical agents offer a non-invasive treatment option, eliminating the need for surgical procedures or more aggressive interventions. The non-invasive nature of topical treatments appeals to individuals who prefer less downtime and minimal discomfort. This characteristic contributes to the widespread adoption of the topical agent segment in the hyperpigmentation treatment market.

By End User Analysis

On the basis of end user, the market is divided into hospitals, dermatological clinics, and others. The hospitals segment garnered a 40.6 % revenue share in the market in 2022. Hospitals often house advanced dermatological departments equipped with state-of-the-art technologies and skilled healthcare professionals. These facilities offer comprehensive services for diagnosing and treating various skin conditions, including hyperpigmentation.



By Disorder Type Analysis

Based on disorder type, the market is classified into age spot, melasma, and other. In 2022, the melasma segment witnessed a 47.81 % revenue share in the market. Melasma is a common pigmentary disorder, and its prevalence has steadily increased. Factors like hormonal changes, genetic predisposition, and sun exposure contribute to the rising incidence of melasma. Melasma is often hormonally mediated and is commonly associated with pregnancy, oral contraceptive use, and hormonal therapies. The condition predominantly affects women, particularly those in their reproductive years.

By Regional Analysis

Region-wise, the treatment market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a 28.57 % revenue share in the treatment market. There is a growing awareness of skincare practices and a shift towards proactive skin health management in the Asia Pacific. Adopting Western beauty standards has influenced skincare preferences in the Asia Pacific region. The increasing emphasis on aesthetics and appearance enhancement drives the demand for cosmetic procedures in the Asia Pacific.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Market Report Segmentation

By Treatment Type
  • Topical Agent
  • Photo Therapy
  • Microdermabrasion
By End User
  • Dermatological Clinics
  • Hospitals
  • Others
By Disorder Type
  • Melasma
  • Age Spot
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Hyperpigmentation Treatment Market, by Treatment Type
1.4.2 Global Hyperpigmentation Treatment Market, by End User
1.4.3 Global Hyperpigmentation Treatment Market, by Disorder Type
1.4.4 Global Hyperpigmentation Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Hyperpigmentation Treatment Market by Treatment Type
4.1 Global Topical Agent Market by Region
4.2 Global Photo Therapy Market by Region
4.3 Global Microdermabrasion Market by Region
Chapter 5. Global Hyperpigmentation Treatment Market by End User
5.1 Global Dermatological Clinics Market by Region
5.2 Global Hospitals Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Hyperpigmentation Treatment Market by Disorder Type
6.1 Global Melasma Market by Region
6.2 Global Age Spot Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Hyperpigmentation Treatment Market by Region
7.1 North America Hyperpigmentation Treatment Market
7.1.1 North America Hyperpigmentation Treatment Market by Treatment Type
7.1.1.1 North America Topical Agent Market by Country
7.1.1.2 North America Photo Therapy Market by Country
7.1.1.3 North America Microdermabrasion Market by Country
7.1.2 North America Hyperpigmentation Treatment Market by End User
7.1.2.1 North America Dermatological Clinics Market by Country
7.1.2.2 North America Hospitals Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Hyperpigmentation Treatment Market by Disorder Type
7.1.3.1 North America Melasma Market by Country
7.1.3.2 North America Age Spot Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Hyperpigmentation Treatment Market by Country
7.1.4.1 US Hyperpigmentation Treatment Market
7.1.4.1.1 US Hyperpigmentation Treatment Market by Treatment Type
7.1.4.1.2 US Hyperpigmentation Treatment Market by End User
7.1.4.1.3 US Hyperpigmentation Treatment Market by Disorder Type
7.1.4.2 Canada Hyperpigmentation Treatment Market
7.1.4.2.1 Canada Hyperpigmentation Treatment Market by Treatment Type
7.1.4.2.2 Canada Hyperpigmentation Treatment Market by End User
7.1.4.2.3 Canada Hyperpigmentation Treatment Market by Disorder Type
7.1.4.3 Mexico Hyperpigmentation Treatment Market
7.1.4.3.1 Mexico Hyperpigmentation Treatment Market by Treatment Type
7.1.4.3.2 Mexico Hyperpigmentation Treatment Market by End User
7.1.4.3.3 Mexico Hyperpigmentation Treatment Market by Disorder Type
7.1.4.4 Rest of North America Hyperpigmentation Treatment Market
7.1.4.4.1 Rest of North America Hyperpigmentation Treatment Market by Treatment Type
7.1.4.4.2 Rest of North America Hyperpigmentation Treatment Market by End User
7.1.4.4.3 Rest of North America Hyperpigmentation Treatment Market by Disorder Type
7.2 Europe Hyperpigmentation Treatment Market
7.2.1 Europe Hyperpigmentation Treatment Market by Treatment Type
7.2.1.1 Europe Topical Agent Market by Country
7.2.1.2 Europe Photo Therapy Market by Country
7.2.1.3 Europe Microdermabrasion Market by Country
7.2.2 Europe Hyperpigmentation Treatment Market by End User
7.2.2.1 Europe Dermatological Clinics Market by Country
7.2.2.2 Europe Hospitals Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Hyperpigmentation Treatment Market by Disorder Type
7.2.3.1 Europe Melasma Market by Country
7.2.3.2 Europe Age Spot Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Hyperpigmentation Treatment Market by Country
7.2.4.1 Germany Hyperpigmentation Treatment Market
7.2.4.1.1 Germany Hyperpigmentation Treatment Market by Treatment Type
7.2.4.1.2 Germany Hyperpigmentation Treatment Market by End User
7.2.4.1.3 Germany Hyperpigmentation Treatment Market by Disorder Type
7.2.4.2 UK Hyperpigmentation Treatment Market
7.2.4.2.1 UK Hyperpigmentation Treatment Market by Treatment Type
7.2.4.2.2 UK Hyperpigmentation Treatment Market by End User
7.2.4.2.3 UK Hyperpigmentation Treatment Market by Disorder Type
7.2.4.3 France Hyperpigmentation Treatment Market
7.2.4.3.1 France Hyperpigmentation Treatment Market by Treatment Type
7.2.4.3.2 France Hyperpigmentation Treatment Market by End User
7.2.4.3.3 France Hyperpigmentation Treatment Market by Disorder Type
7.2.4.4 Russia Hyperpigmentation Treatment Market
7.2.4.4.1 Russia Hyperpigmentation Treatment Market by Treatment Type
7.2.4.4.2 Russia Hyperpigmentation Treatment Market by End User
7.2.4.4.3 Russia Hyperpigmentation Treatment Market by Disorder Type
7.2.4.5 Spain Hyperpigmentation Treatment Market
7.2.4.5.1 Spain Hyperpigmentation Treatment Market by Treatment Type
7.2.4.5.2 Spain Hyperpigmentation Treatment Market by End User
7.2.4.5.3 Spain Hyperpigmentation Treatment Market by Disorder Type
7.2.4.6 Italy Hyperpigmentation Treatment Market
7.2.4.6.1 Italy Hyperpigmentation Treatment Market by Treatment Type
7.2.4.6.2 Italy Hyperpigmentation Treatment Market by End User
7.2.4.6.3 Italy Hyperpigmentation Treatment Market by Disorder Type
7.2.4.7 Rest of Europe Hyperpigmentation Treatment Market
7.2.4.7.1 Rest of Europe Hyperpigmentation Treatment Market by Treatment Type
7.2.4.7.2 Rest of Europe Hyperpigmentation Treatment Market by End User
7.2.4.7.3 Rest of Europe Hyperpigmentation Treatment Market by Disorder Type
7.3 Asia Pacific Hyperpigmentation Treatment Market
7.3.1 Asia Pacific Hyperpigmentation Treatment Market by Treatment Type
7.3.1.1 Asia Pacific Topical Agent Market by Country
7.3.1.2 Asia Pacific Photo Therapy Market by Country
7.3.1.3 Asia Pacific Microdermabrasion Market by Country
7.3.2 Asia Pacific Hyperpigmentation Treatment Market by End User
7.3.2.1 Asia Pacific Dermatological Clinics Market by Country
7.3.2.2 Asia Pacific Hospitals Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Hyperpigmentation Treatment Market by Disorder Type
7.3.3.1 Asia Pacific Melasma Market by Country
7.3.3.2 Asia Pacific Age Spot Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Hyperpigmentation Treatment Market by Country
7.3.4.1 China Hyperpigmentation Treatment Market
7.3.4.1.1 China Hyperpigmentation Treatment Market by Treatment Type
7.3.4.1.2 China Hyperpigmentation Treatment Market by End User
7.3.4.1.3 China Hyperpigmentation Treatment Market by Disorder Type
7.3.4.2 Japan Hyperpigmentation Treatment Market
7.3.4.2.1 Japan Hyperpigmentation Treatment Market by Treatment Type
7.3.4.2.2 Japan Hyperpigmentation Treatment Market by End User
7.3.4.2.3 Japan Hyperpigmentation Treatment Market by Disorder Type
7.3.4.3 India Hyperpigmentation Treatment Market
7.3.4.3.1 India Hyperpigmentation Treatment Market by Treatment Type
7.3.4.3.2 India Hyperpigmentation Treatment Market by End User
7.3.4.3.3 India Hyperpigmentation Treatment Market by Disorder Type
7.3.4.4 South Korea Hyperpigmentation Treatment Market
7.3.4.4.1 South Korea Hyperpigmentation Treatment Market by Treatment Type
7.3.4.4.2 South Korea Hyperpigmentation Treatment Market by End User
7.3.4.4.3 South Korea Hyperpigmentation Treatment Market by Disorder Type
7.3.4.5 Singapore Hyperpigmentation Treatment Market
7.3.4.5.1 Singapore Hyperpigmentation Treatment Market by Treatment Type
7.3.4.5.2 Singapore Hyperpigmentation Treatment Market by End User
7.3.4.5.3 Singapore Hyperpigmentation Treatment Market by Disorder Type
7.3.4.6 Malaysia Hyperpigmentation Treatment Market
7.3.4.6.1 Malaysia Hyperpigmentation Treatment Market by Treatment Type
7.3.4.6.2 Malaysia Hyperpigmentation Treatment Market by End User
7.3.4.6.3 Malaysia Hyperpigmentation Treatment Market by Disorder Type
7.3.4.7 Rest of Asia Pacific Hyperpigmentation Treatment Market
7.3.4.7.1 Rest of Asia Pacific Hyperpigmentation Treatment Market by Treatment Type
7.3.4.7.2 Rest of Asia Pacific Hyperpigmentation Treatment Market by End User
7.3.4.7.3 Rest of Asia Pacific Hyperpigmentation Treatment Market by Disorder Type
7.4 LAMEA Hyperpigmentation Treatment Market
7.4.1 LAMEA Hyperpigmentation Treatment Market by Treatment Type
7.4.1.1 LAMEA Topical Agent Market by Country
7.4.1.2 LAMEA Photo Therapy Market by Country
7.4.1.3 LAMEA Microdermabrasion Market by Country
7.4.2 LAMEA Hyperpigmentation Treatment Market by End User
7.4.2.1 LAMEA Dermatological Clinics Market by Country
7.4.2.2 LAMEA Hospitals Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Hyperpigmentation Treatment Market by Disorder Type
7.4.3.1 LAMEA Melasma Market by Country
7.4.3.2 LAMEA Age Spot Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Hyperpigmentation Treatment Market by Country
7.4.4.1 Brazil Hyperpigmentation Treatment Market
7.4.4.1.1 Brazil Hyperpigmentation Treatment Market by Treatment Type
7.4.4.1.2 Brazil Hyperpigmentation Treatment Market by End User
7.4.4.1.3 Brazil Hyperpigmentation Treatment Market by Disorder Type
7.4.4.2 Argentina Hyperpigmentation Treatment Market
7.4.4.2.1 Argentina Hyperpigmentation Treatment Market by Treatment Type
7.4.4.2.2 Argentina Hyperpigmentation Treatment Market by End User
7.4.4.2.3 Argentina Hyperpigmentation Treatment Market by Disorder Type
7.4.4.3 UAE Hyperpigmentation Treatment Market
7.4.4.3.1 UAE Hyperpigmentation Treatment Market by Treatment Type
7.4.4.3.2 UAE Hyperpigmentation Treatment Market by End User
7.4.4.3.3 UAE Hyperpigmentation Treatment Market by Disorder Type
7.4.4.4 Saudi Arabia Hyperpigmentation Treatment Market
7.4.4.4.1 Saudi Arabia Hyperpigmentation Treatment Market by Treatment Type
7.4.4.4.2 Saudi Arabia Hyperpigmentation Treatment Market by End User
7.4.4.4.3 Saudi Arabia Hyperpigmentation Treatment Market by Disorder Type
7.4.4.5 South Africa Hyperpigmentation Treatment Market
7.4.4.5.1 South Africa Hyperpigmentation Treatment Market by Treatment Type
7.4.4.5.2 South Africa Hyperpigmentation Treatment Market by End User
7.4.4.5.3 South Africa Hyperpigmentation Treatment Market by Disorder Type
7.4.4.6 Nigeria Hyperpigmentation Treatment Market
7.4.4.6.1 Nigeria Hyperpigmentation Treatment Market by Treatment Type
7.4.4.6.2 Nigeria Hyperpigmentation Treatment Market by End User
7.4.4.6.3 Nigeria Hyperpigmentation Treatment Market by Disorder Type
7.4.4.7 Rest of LAMEA Hyperpigmentation Treatment Market
7.4.4.7.1 Rest of LAMEA Hyperpigmentation Treatment Market by Treatment Type
7.4.4.7.2 Rest of LAMEA Hyperpigmentation Treatment Market by End User
7.4.4.7.3 Rest of LAMEA Hyperpigmentation Treatment Market by Disorder Type
Chapter 8. Company Profiles
8.1 Vivier Pharma Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Pierre Fabre S.A
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.3 SWOT Analysis
8.3 Aerolase
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 L'Oréal S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.5 SWOT Analysis
8.5 The Procter & Gamble Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Galderma S.A.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 CP Skin Health Group, Inc. (The Colgate Palmolive Company)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Trophy Skin Products LLC
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Episciences, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis
Chapter 9. Winning Imperatives of Hyperpigmentation Treatment Market

Companies Mentioned

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Methodology

Loading
LOADING...